NetMed, Inc. (NTME)
For informational purposes only. Not financial advice. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
NetMed, Inc. (NTME) with AI Score 44/100 (Weak). NetMed, Inc. is a company based in Columbus, Ohio, that was previously involved in research and development of ceramic-based technology for gas separation. Market cap: 0, Sector: Financial services.
Last analyzed: Mar 16, 2026NetMed, Inc. (NTME) Financial Services Profile
NetMed, Inc., based in Columbus, Ohio, is currently evaluating new business opportunities after ceasing its prior research and development activities in ceramic-based gas separation technology. With no significant operations reported since 2001, the company operates within the financial services sector, specifically asset management, while seeking a new strategic direction.
Investment Thesis
NetMed, Inc. presents a speculative investment opportunity due to its current lack of significant operations and ongoing evaluation of new business ventures. With a market capitalization of $0.00B, the company's value is primarily based on its potential future endeavors. A negative P/E ratio indicates a lack of profitability, and a beta of -2.96 suggests an inverse correlation to market movements, though this may be unreliable given the company's inactivity. The absence of a dividend yield further underscores the speculative nature of the investment. Potential catalysts hinge on the successful identification and implementation of a new business strategy, which could drive future growth. However, significant risks exist, including the uncertainty of finding a viable business opportunity and the potential for further delays or unsuccessful ventures. Investors should carefully consider the high level of uncertainty and speculative nature of this investment.
Based on FMP financials and quantitative analysis
Key Highlights
- Market Cap: $0.00B indicating the company's small size and limited market presence.
- P/E Ratio: -0.00 reflecting the company's lack of earnings and profitability.
- Beta: -2.96 suggesting an inverse correlation with the market, although potentially unreliable due to the company's inactivity.
- Dividend Yield: None, indicating no current return of capital to investors through dividends.
- Status: Evaluating new business opportunities since 2001, highlighting a prolonged period of transition and uncertainty.
Competitors & Peers
Strengths
- Existing corporate structure and history.
- Potential for a fresh start with a new business venture.
- Location in Columbus, Ohio, a growing business hub.
Weaknesses
- Lack of significant operations since 2001.
- Uncertainty regarding future business strategy.
- Limited financial resources.
- Negative P/E ratio and no dividend yield.
Catalysts
- Upcoming: Announcement of a new business venture could significantly boost investor confidence.
- Ongoing: Evaluation of potential strategic partnerships may lead to new opportunities.
- Ongoing: Efforts to attract investment could provide capital for growth.
Risks
- Potential: Failure to identify a viable business opportunity could lead to further decline.
- Potential: Limited financial resources may hinder growth prospects.
- Ongoing: Lack of transparency and disclosure increases investment risk.
- Ongoing: The OTC Other tier listing carries inherent risks of illiquidity and manipulation.
Growth Opportunities
- New Business Venture: NetMed's primary growth opportunity lies in identifying and successfully launching a new business venture. The company has been evaluating opportunities since 2001, and a successful launch could revitalize the company. The market size for potential ventures is highly variable depending on the chosen industry, but a well-executed strategy could lead to significant growth within 3-5 years.
- Strategic Partnership: Forming a strategic partnership with an established company in the financial services sector could provide NetMed with access to resources, expertise, and market channels. This could accelerate the implementation of a new business strategy and reduce the risks associated with entering a new market. The timeline for establishing a partnership could range from 6-18 months.
- Acquisition Target: NetMed could position itself as an attractive acquisition target for a larger company seeking to expand its portfolio or enter new markets. The company's existing infrastructure and history could provide value to a potential acquirer. The timeline for a potential acquisition is uncertain but could occur within the next 2-3 years.
- Technological Innovation: Investing in and developing innovative technologies within the financial services sector could provide NetMed with a competitive edge. This could involve developing new investment platforms, data analytics tools, or other fintech solutions. The timeline for developing and launching new technologies could range from 2-4 years.
- Regulatory Compliance Services: With increasing regulatory scrutiny in the financial services sector, NetMed could explore opportunities in providing regulatory compliance services to other companies. This could involve helping companies navigate complex regulations, implement compliance programs, and manage regulatory risks. The market for compliance services is growing, and NetMed could establish a presence within 1-2 years.
Opportunities
- Identifying a high-growth market segment within financial services.
- Forming strategic partnerships to accelerate growth.
- Attracting investment to fund new ventures.
- Leveraging technological innovation to gain a competitive edge.
Threats
- Intense competition in the financial services sector.
- Evolving regulatory landscape.
- Economic downturn impacting investment activity.
- Failure to identify a viable business opportunity.
Competitive Advantages
- Currently, NetMed does not have a discernible moat.
- Potential competitive advantages could arise from a successful new business venture.
- First-mover advantage in a niche market segment could provide a future moat.
About NTME
NetMed, Inc. was founded in 1989 and is headquartered in Columbus, Ohio. Initially, the company focused on the research and development of a proprietary ceramic-based technology designed for the separation of oxygen from ambient air and other gases. This technology aimed to provide a more efficient and cost-effective method for gas separation, potentially serving industries such as healthcare, manufacturing, and environmental control. However, as of December 31, 2001, NetMed, Inc. ceased its significant operations related to this technology. Since then, the company has been in a state of transition, actively evaluating various other business opportunities. The specific nature of these potential opportunities remains undisclosed, but the company's presence within the financial services sector, specifically asset management, suggests a possible shift towards investment-related activities. Given its current state, NetMed, Inc. does not have any active products or services in the market. Its future direction will depend on the outcome of its ongoing evaluation of new business ventures. The company's long history and existing infrastructure could provide a foundation for future growth, pending the successful identification and execution of a viable business strategy.
What They Do
- Previously engaged in research and development of ceramic-based gas separation technology.
- Currently evaluating new business opportunities in the financial services sector.
- Seeking to identify a viable business strategy for future growth.
- Potentially exploring strategic partnerships or acquisition opportunities.
- Aiming to revitalize the company after a period of inactivity.
Business Model
- Currently, NetMed does not have an active business model.
- The company is exploring potential business models within the financial services sector.
- Future revenue generation will depend on the successful implementation of a new business strategy.
Industry Context
NetMed, Inc. operates within the financial services sector, specifically categorized under asset management, although it currently lacks active operations in this area. The asset management industry is characterized by intense competition, evolving regulatory landscapes, and increasing demand for innovative investment strategies. Companies in this sector typically manage investments on behalf of individuals and institutions. Given NetMed's current state of evaluating new business opportunities, its future success will depend on its ability to adapt to these industry dynamics and carve out a competitive niche.
Key Customers
- Currently, NetMed does not have any active customers.
- Future customer segments will depend on the nature of the new business venture.
- Potential customer segments could include individual investors, institutional investors, or other financial institutions.
Financials
Chart & Info
NetMed, Inc. (NTME) stock price: Price data unavailable
Latest News
-
Truist Financial (TFC) Announces New Leadership Appointments
Yahoo Finance · Mar 17, 2026
-
LaFleur Minerals Bolsters Executive Team and Announces Webinar to Present Positive PEA for Beacon Gold Mill Restart
Business Insider · Mar 16, 2026
Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for NTME.
Price Targets
Wall Street price target analysis for NTME.
MoonshotScore
What does this score mean?
The MoonshotScore rates NTME's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
NTME OTC Market Information
The OTC Other tier represents the lowest tier of the OTC Markets, indicating that NetMed, Inc. is not required to meet specific financial standards or undergo regular audits like companies listed on the NYSE or NASDAQ. Companies in this tier may have limited information available to investors, and there is no guarantee of ongoing disclosure. This tier is often associated with higher risk and speculative investments due to the lack of regulatory oversight and transparency compared to listed exchanges.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
- Limited or no financial disclosure.
- Potential for fraud or manipulation.
- High price volatility.
- Illiquidity and difficulty in trading shares.
- Shell risk due to lack of operations.
- Verify the company's legal standing and registration.
- Attempt to obtain financial information, even if limited.
- Assess the background and experience of the company's management.
- Research any potential legal or regulatory issues.
- Understand the company's business plan and prospects.
- Evaluate the risks associated with investing in an OTC Other stock.
- Consult with a financial advisor before investing.
- Longevity of the company's existence (founded in 1989).
- Registered office in Columbus, Ohio.
- Previous involvement in research and development activities.
- Evaluation of new business opportunities indicates ongoing efforts to revitalize the company.
Common Questions About NTME
What does NetMed, Inc. do?
NetMed, Inc. previously focused on research and development of ceramic-based gas separation technology. However, since 2001, the company has had no significant operations and is currently evaluating new business opportunities within the financial services sector, specifically asset management. The company's future direction depends on its ability to identify and implement a viable business strategy, potentially through strategic partnerships, acquisitions, or new ventures. Investors should note the speculative nature of the company's current state.
What do analysts say about NTME stock?
As of 2026-03-16, there is no available analyst coverage for NTME stock due to the company's lack of significant operations and its listing on the OTC Other tier. Key valuation metrics such as P/E ratio and dividend yield are not meaningful in the current context. Any potential growth considerations depend entirely on the company's ability to successfully launch a new business venture. Investors should conduct their own thorough due diligence before considering an investment in NTME.
What are the main risks for NTME?
The main risks for NetMed, Inc. include the uncertainty of identifying a viable business opportunity, limited financial resources, and the inherent risks associated with trading on the OTC Other tier. The lack of financial disclosure and transparency increases the potential for fraud or manipulation. Additionally, the stock is likely to be illiquid and subject to high price volatility. Investors should carefully consider these risks before investing in NTME.
What are the key factors to evaluate for NTME?
NetMed, Inc. (NTME) currently holds an AI score of 44/100, indicating low score. Key strength: Existing corporate structure and history.. Primary risk to monitor: Potential: Failure to identify a viable business opportunity could lead to further decline.. This is not financial advice.
How frequently does NTME data refresh on this page?
NTME prices update in real time during U.S. market hours (9:30 AM-4:00 PM ET, weekdays). Fundamentals refresh after quarterly or annual filings. Analyst ratings and AI insights update daily. News is aggregated continuously from financial sources.
What has driven NTME's recent stock price performance?
Recent price movement in NetMed, Inc. (NTME) can be influenced by earnings results, analyst revisions, sector rotation, and broader market sentiment. Notable catalyst: Existing corporate structure and history.. Check the News and Technical Analysis tabs for the latest drivers. Past performance does not predict future results.
Should investors consider NTME overvalued or undervalued right now?
Determining whether NetMed, Inc. (NTME) is overvalued or undervalued requires examining multiple metrics. Compare valuation ratios (P/E, P/S, EV/EBITDA) against sector peers for a comprehensive view.
What research should beginners do before buying NTME?
Before investing in NetMed, Inc. (NTME), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Information is limited due to the company's lack of significant operations and OTC Other tier listing.
- Financial data is based on available information as of December 31, 2001, and may not be current.